Anthos Therapeutics announces that 1287 patients enrolled across 95 global study sites in the AZALEA-TIMI 71 Ph2 study evaluating the safety and tolerability of abelacimab compared to rivaroxaban Abelacimab is a monoclonal antibody with dual activity against Factor XI and Factor XIa administered monthly CAMBRIDGE, Mass., Dec. 7, 2021 /PRNewswire/ — Anthos Therapeutics, […]
Rhythm
Boston Scientific Initiates Trial to Evaluate Industry’s First Modular CRM System
Trial studying communication between cardiac rhythm management devices aims to expand treatment options for patients who require an ICD MARLBOROUGH, Mass., Dec. 2, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of the mCRM™ Modular Therapy System. The mCRM […]
Valbiotis Announces That It Has Submitted to the Competent Authorities the Three Clinical Protocols for TOTUM•854 Indicated in the Reduction of Blood Pressure and Presents Its Comprehensive Clinical Development Plan
The INSIGHT international, multicenter, randomized, placebo-controlled pivotal Phase II/III clinical study will be conducted with a 3.7 g/day dose of TOTUM•854 on 400 volunteers; The INSIGHT 2 international, multicenter, randomized, placebo-controlled Phase II/III clinical study will be conducted with a 2.6 g/day dose of TOTUM•854 on 400 volunteers; The clinical […]
Eko and the National Association of Free & Charitable Clinics Partner to Improve Cardiovascular Care in Medically Underserved Communities
Eko donates smart stethoscope and telehealth kits to free & charitable clinics across 33 states, enhancing cardiac screening services to uninsured and medically underserved Americans OAKLAND, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced its partnership with the National Association of Free & Charitable Clinics (NAFC). […]
Cardiologs’ AI Receives 510(k) Clearance for Pediatric Use
New data shows improved deep learning algorithm performs equally across all age groups, enabling more patients to benefit from the company’s cardiac diagnostics AI platform PARIS and BOSTON, Nov. 22, 2021 /PRNewswire/ — Cardiologs announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to use its AI-powered cardiac diagnostics platform […]
Cardialen Receives FDA Approval to Conduct Clinical Trial of Low-Energy Atrial Fibrillation Treatment
U.S. Food and Drug Administration approval of a clinical trial of Cardialen’s low-energy defibrillation and cardioversion therapy expands the number of leading clinical institutions evaluating its promising MultiPulse™ Therapy. MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin a […]
LOKELMA® Granted Fast Track Designation in the US to Reduce Cardiovascular Outcomes in Patients on Chronic Hemodialysis With Hyperkalemia
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca has been granted Fast Track Designation in the United States (US) for the development of LOKELMA® (sodium zirconium cyclosilicate) to reduce arrhythmia-related cardiovascular outcomes in patients on chronic hemodialysis with recurrent hyperkalemia (HK). The designation is based on the potential of LOKELMA to reduce serious adverse CV outcomes […]
BioSig Initiates Artificial Intelligence Development Program with Technion – Israel Institute of Technology
Company partners with the leading academic institution on research and development of AI-driven methods for atrial fibrillation procedures Westport, CT, Nov. 16, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal […]
Sky Labs’ CART-I, a Wearable Heart Monitoring Medical Device, Advances Into the British Medical Device Market
– As the world’s first ring-type medical device to monitor heart signals, CART-I continually measures atrial fibrillation 24/7 – In-house developed AI technology is used to provide significant medical data to patients and medical professionals, leading to an increased atrial fibrillation diagnosis rate – Discount promotion is planned in Britain […]
Milestone Pharmaceuticals Announces Presentation of Heart Rate Analysis of NODE-301 Trial of Etripamil in Patients with PSVT
– Etripamil significantly decreased heart rate during SVT episodes and independent of conversion to SR – – HR changes occurred within 5 minutes and were sustained for 60 minutes – – Data presented at AHA Scientific Sessions 2021 – MONTREAL and CHARLOTTE, N.C., Nov. 15, 2021 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical […]



